Onuigbo MA - Search Results

1

Hospital Readmission among New Dialysis Patients Associated with Young Age and Poor Functional Status.

Hickson LJ, Thorsteinsdottir B, Ramar P, Reinalda MS, Crowson CS, Williams AW, Albright RC, Onuigbo MA, Rule AD, Shah ND. Hickson LJ, et al. Among authors: onuigbo ma. Nephron. 2018;139(1):1-12. doi: 10.1159/000485985. Epub 2018 Jan 9. Nephron. 2018. PMID: 29402792 Free PMC article.

2

Tolerability and Healthcare Utilization in Maintenance Hemodialysis Patients Undergoing Treatment for Tuberculosis-Related Conditions.

Hamadah AM, Beaulieu LM, Wilson JW, Aksamit TR, Gregoire JR, Williams AW, Dillon JJ, Albright RC, Onuigbo M, Iyer VK, Hickson LJ. Hamadah AM, et al. Nephron. 2016;132(3):198-206. doi: 10.1159/000444148. Epub 2016 Feb 10. Nephron. 2016. PMID: 26859893 Free PMC article.

3

Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.

Hickson LJ, Negrotto SM, Onuigbo M, Scott CG, Rule AD, Norby SM, Albright RC, Casey ET, Dillon JJ, Pellikka PA, Pislaru SV, Best PJM, Villarraga HR, Lin G, Williams AW, Nkomo VT. Hickson LJ, et al. J Am Coll Cardiol. 2016 Mar 15;67(10):1173-1182. doi: 10.1016/j.jacc.2015.12.052. J Am Coll Cardiol. 2016. PMID: 26965538 Free PMC article.

4

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy.

Chen JC, Thorsteinsdottir B, Vaughan LE, Feely MA, Albright RC, Onuigbo M, Norby SM, Gossett CL, D'Uscio MM, Williams AW, Dillon JJ, Hickson LJ. Chen JC, et al. Among authors: onuigbo m. Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1172-1179. doi: 10.2215/CJN.00590118. Epub 2018 Jul 19. Clin J Am Soc Nephrol. 2018. PMID: 30026285 Free PMC article.

5

Nondialytic therapy for end-stage renal disease is an underutilized care paradigm in the United States: time for a more robust reappraisal of this treatment option.

Onuigbo MA. Onuigbo MA. Adv Perit Dial. 2013;29:73-6. Adv Perit Dial. 2013. PMID: 24344497

6

Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease - a call for caution.

Onuigbo MA. Onuigbo MA. Nephron Clin Pract. 2009;113(2):c63-9, discussion c70. doi: 10.1159/000228536. Epub 2009 Jul 14. Nephron Clin Pract. 2009. PMID: 19602900 Free article. Review.

7

De novo HBV infection in a Mayo Clinic hemodialysis population: economic impact of reduced HBV testing and a call for changes in current US CDC guidelines on HBV testing protocols.

Onuigbo MA, Onuigbo NT. Onuigbo MA, et al. Among authors: onuigbo nt. Hemodial Int. 2012 Oct;16 Suppl 1:S32-8. doi: 10.1111/j.1542-4758.2012.00748.x. Hemodial Int. 2012. PMID: 23036034

8

Drug-induced encephalopathy secondary to non renal dosing of common medications in Two dialysis patients.

Onuigbo MA, Nye D, Iloanya PC. Onuigbo MA, et al. Adv Perit Dial. 2009;25:89-91. Adv Perit Dial. 2009. PMID: 19886325

9

Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.

Onuigbo MA. Onuigbo MA. Ren Fail. 2010;32(8):954-8. doi: 10.3109/0886022X.2010.502608. Ren Fail. 2010. PMID: 20722563

10

Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?

Onuigbo MA. Onuigbo MA. Nephron Clin Pract. 2011;118(4):c407-19. doi: 10.1159/000324164. Epub 2011 Mar 7. Nephron Clin Pract. 2011. PMID: 21389735 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page